Anti-IgE Drug Scratches Itch of Chronic Hives
MedPage Today
BALTIMORE -- The anti-immunoglobulin E (IgE) monoclonal antibody omalizumab (Xolair) durably eased itch severity in chronic urticaria uncontrolled by antihistamines, a pivotal trial showed.
|
Scooped by
Gilbert C FAURE
onto Allergy (and clinical immunology) November 13, 2013 2:34 PM
|